Yong Yin

5PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 16, 2026
A multiple-responsive nano-prodrug combining chemo-differentiation-cancer stem cell inhibition toward triple-negative breast cancer.

Yanting Li, Mengdan Ning, Haoping Long

|Dec 04, 2025
KY216-tubulin complex captures VASH2 to inhibit NSCLC metastasis.

Xiao-Yu He, Cheng-Yan Liu, Xin-Yu Ding

|Feb 09, 2024
Discovery of Novel Isoquinoline Analogues as Dual Tubulin Polymerization/V-ATPase Inhibitors with Immunogenic Cell Death Induction.

Jiafu Leng, Yongjun Zhao, Shifang Zhao

|Jul 15, 2023
Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer.

Tingting Chen, Jiafu Leng, Jun Tan

|Dec 06, 2022
Discovery of Novel N-Heterocyclic-Fused Deoxypodophyllotoxin Analogues as Tubulin Polymerization Inhibitors Targeting the Colchicine-Binding Site for Cancer Treatment.

Jiafu Leng, Yongjun Zhao, Ping Sheng

Pageof 1

Frequent Collaborators

4 joint publications

Lingyi Kong

1 joint publications

Xiaobing Wang

1 joint publications

Jun Luo

1 joint publications

Xin-Yu Ding